Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Tight junction,0.4928973813652527,1.9550386730646505,0.0,0.03368974374290663,0.02,32/169,24.08%,MYL12B;SLC9A3R1;MYH14;YBX3;MYL12A;ACTG1;ERBB2;PRKAA1;ROCK1;CLDN7;ACTN1;TUBA4A;ARPC3;RDX;PPP2R2A;DLG1;CRB3;TJP1;MYL6B;AFDN;ARPC2;F11R;ARPC1B;PRKCI;MAPK8;TJP2;PRKACA;ARHGAP17;ITGB1;ARPC5;ACTN4;CDK4
prerank,Adherens junction,0.5153550264932701,1.870062370366436,0.0,0.03930470103339108,0.05,20/71,23.87%,CSNK2A1;ACTG1;ERBB2;ACTN1;CTNNB1;BAIAP2;MAPK3;TJP1;TGFBR2;AFDN;YES1;CDH1;CTNND1;FYN;IGF1R;LMO7;WASF1;ACP1;ACTN4;VCL
prerank,Focal adhesion,0.4463505958248862,1.748296115921497,0.0,0.16470541385421023,0.28,38/201,23.87%,LAMA3;MYL12B;CAV1;SHC1;MYL12A;AKT2;ACTG1;ERBB2;ARHGAP35;COL6A1;PPP1CB;FN1;DIAPH1;ROCK1;ACTN1;CTNNB1;LAMA5;PPP1R12A;FLNA;MAPK3;ARHGAP5;PDGFB;SOS1;ITGB4;MAPK8;LAMC1;CRK;FYN;PIK3CB;IGF1R;THBS1;RAP1B;AKT1;GRB2;PTK2;ITGB1;ACTN4;VCL
prerank,Shigellosis,0.4284355870768385,1.7413581531635316,0.0,0.13195149632638434,0.3,48/246,28.49%,MYL12B;GABARAP;C3;IKBKG;UBE2D3;MYL12A;AKT2;ACTG1;SKP1;UBB;CAST;DIAPH1;ROCK1;ACTN1;TAB2;CAPNS1;ARPC3;MAPK3;PLCD3;UBE2V1;PPID;ARPC2;ARPC1B;BECN1;PIK3C3;TBK1;UBE2D2;MAPK8;IRF3;CRK;FNBP1;PIK3CB;MAPK14;BCL10;AKT1;UBE2D1;WASF1;UBE2V2;PTK2;ITGB1;ARPC5;ACTN4;VCL;CALCOCO2;ACTR2;RIPK2;SQSTM1;FBXW11
prerank,Bacterial invasion of epithelial cells,0.457922462518393,1.7297786772111603,0.0,0.11229914580968879,0.3,19/77,23.87%,CAV1;SHC1;ACTG1;DNM2;FN1;CTNNB1;ARPC3;ARPC2;ARPC1B;CDH1;CRK;PIK3CB;CD2AP;WASF1;PTK2;CLTC;ITGB1;ARPC5;VCL
prerank,Viral myocarditis,0.5666768105499489,1.6874963598738417,0.012987012987012988,0.140373932262111,0.37,13/60,39.19%,CAV1;EIF4G2;EIF4G1;CD55;ACTG1;FYN;BID;EIF4G3;ACTB;RAC1;DAG1;CCND1;CASP3
prerank,Endocytosis,0.3959424084035148,1.6871282989069982,0.0,0.12192478687909068,0.38,53/252,23.47%,CAV1;AP2M1;RAB11A;USP8;SNF8;DNM2;RAB5A;PDCD6IP;AGAP1;STAMBP;CHMP2B;AP2B1;ARPC3;RAB7A;CAPZA2;ARFGAP3;EHD1;ASAP1;TGFBR2;CAPZA1;RAB10;ARPC2;SH3GLB2;ARPC1B;SNX3;VPS26A;CHMP3;IST1;WWP1;TSG101;PRKCI;VPS36;CHMP4C;WASHC3;VPS35;ARAP1;CHMP5;ARF3;WASHC2C;IGF1R;IQSEC1;SPART;SNX2;VPS37A;VTA1;SNX4;SNX5;CHMP2A;SMAP1;CLTC;AGAP3;AP2S1;ARPC5
prerank,Hepatocellular carcinoma,0.4376933130448924,1.6819311484058788,0.0,0.10949166716444657,0.39,23/168,19.36%,SHC1;AKT2;ACTG1;ACTL6A;SMARCD2;ARID1A;BRD7;CDKN2A;CTNNB1;SMARCC1;MGST3;DVL1;MAPK3;SMARCE1;MGST1;TGFBR2;SOS1;CSNK1A1;DVL3;PIK3CB;IGF1R;AKT1;GRB2
prerank,Regulation of actin cytoskeleton,0.4047627422301278,1.6303546719173976,0.011627906976744186,0.15597103584678998,0.57,34/218,25.08%,MYL12B;MYH14;MYL12A;RRAS2;ACTG1;ARHGAP35;PPP1CB;FN1;DIAPH1;ROCK1;ACTN1;BAIAP2;NCKAP1;ARPC3;RDX;PPP1R12A;MAPK3;PDGFB;SOS1;ARPC2;ITGB4;ARPC1B;CFL1;CRK;PIK3CB;ENAH;WASF1;PTK2;ITGB1;ARPC5;ACTN4;GNA12;VCL;PAK1
prerank,Ubiquitin mediated proteolysis,0.4151886200494568,1.608695558307056,0.010869565217391304,0.18304760766979272,0.65,39/140,34.12%,UBE2D3;UBE2A;UBE2H;SKP1;UBB;CUL3;UBE4A;UBE2F;PIAS1;TRIP12;CUL5;UBE2J2;UBE2G1;WWP1;UBE2D2;CUL4B;UBE2E3;HUWE1;ELOB;UBE2D1;MID1;FANCL;HERC4;HERC1;UBE2B;ANAPC2;PML;UBE2E1;FZR1;FBXW11;ITCH;CUL4A;ANAPC13;ANAPC7;CDC16;ANAPC5;XIAP;SYVN1;UBE3A
prerank,Human papillomavirus infection,0.39152895364250834,1.6034717861402044,0.0,0.17661592931887418,0.68,47/331,29.27%,LAMA3;SLC9A3R1;CHD4;IKBKG;GNAS;AKT2;LFNG;COL6A1;PPP2R5C;FN1;CTNNB1;LAMA5;PPP2R5E;DVL1;ATP6V0E1;PPP2R2A;DLG1;IFNAR1;MAPK3;CRB3;SOS1;ITGB4;PPP2R5A;PRKCI;CSNK1A1;TBK1;LAMC1;IRF3;RBPJ;DVL3;PIK3CB;JAK1;THBS1;ATP6V1C1;AKT1;GRB2;PRKACA;PTK2;ITGB1;CDK4;ATP6AP1;ATP6V1A;STAT1;TYK2;FZD6;NRAS;BCAP31
prerank,Glutathione metabolism,0.5211190858668425,1.5954492985798896,0.012195121951219513,0.18622941680106725,0.71,10/57,23.38%,PRDX6;GPX8;GPX3;MGST3;GCLM;MGST1;G6PD;ODC1;GSR;GCLC
prerank,Salmonella infection,0.3821270170632269,1.5881561413794227,0.010869565217391304,0.1883170291270166,0.73,45/249,27.84%,MYL12B;IKBKG;MYL12A;AKT2;ACTG1;SKP1;DNM2;RAB5A;ANXA2;CTNNB1;TAB2;DYNC1I2;EXOC5;PLEKHM2;NCKAP1;TUBA4A;ARPC3;RAB7A;FLNA;MAPK3;VPS41;HSP90B1;ARPC2;ACTR10;ARPC1B;MAP2K4;PIK3C3;MAPK8;PIK3CB;MAPK14;HSP90AA1;AKT1;DCTN2;GCC2;ARPC5;DCTN6;KPNA1;DYNC1H1;PAK1;AHNAK2;EXOC7;MAP2K3;ACTR2;PIK3C2A;RIPK2
prerank,PI3K-Akt signaling pathway,0.38487872603212325,1.5480623802062434,0.010416666666666666,0.24705812078131537,0.82,36/354,26.34%,LAMA3;IKBKG;AKT2;ERBB2;COL6A1;PRKAA1;PPP2R5C;YWHAZ;FN1;LAMA5;PPP2R5E;PPP2R2A;IFNAR1;MAPK3;PDGFB;HSP90B1;SOS1;ITGB4;PPP2R5A;YWHAQ;ERBB3;LAMC1;PIK3CB;JAK1;IGF1R;THBS1;HSP90AA1;AKT1;GRB2;YWHAB;PTK2;KITLG;ITGB1;CDK4;THEM4;YWHAE
prerank,Pathogenic Escherichia coli infection,0.3901663648539111,1.5422030862687164,0.02247191011235955,0.240320172032734,0.83,30/197,25.08%,SLC9A3R1;MYH14;TMBIM6;IKBKG;NCK1;MYO1C;ACTG1;SEC24C;ROCK1;CLDN7;BAIAP2;TAB2;NCKAP1;TUBA4A;ARPC3;MAPK3;TJP1;MYO1E;ARPC2;ARPC1B;MAPK8;RAB1A;FYN;MAPK14;WASF1;BAIAP2L1;ITGB1;ARPC5;GNA12;PAK1
prerank,Amino sugar and nucleotide sugar metabolism,0.5220238749060234,1.5254688947819348,0.025974025974025976,0.26249925333014756,0.85,8/48,21.97%,GMPPA;CMAS;HEXB;UGP2;GFPT1;PGM2;UAP1;UXS1
prerank,Leukocyte transendothelial migration,0.4257919943123406,1.5226542631262947,0.024096385542168676,0.2530033696771224,0.86,19/114,23.87%,MYL12B;MYL12A;ACTG1;ARHGAP35;ROCK1;CLDN7;ACTN1;CTNNB1;ARHGAP5;AFDN;F11R;CTNND1;PIK3CB;MAPK14;RAP1B;PTK2;ITGB1;ACTN4;VCL
prerank,Amoebiasis,0.44602122924821247,1.5170469714458972,0.012345679012345678,0.25454473050196125,0.87,13/102,23.87%,LAMA3;GNAS;RAB5A;FN1;ACTN1;LAMA5;RAB7A;LAMC1;PIK3CB;PRKACA;PTK2;ACTN4;VCL
prerank,RNA transport,0.3899246060273414,1.5134038621165378,0.0,0.25060440959635816,0.87,42/186,32.77%,EIF4G2;EIF4A1;CLNS1A;EIF4G1;PAIP1;FXR1;EEF1A1;EIF3CL;SAP18;EIF3E;PNN;POP4;TPR;EIF3H;NUP153;RNPS1;PABPC1;EIF5;RANBP2;NXT2;EIF4A2;SUMO1;FUS;XPOT;NUP50;EIF1;THOC5;EIF3J;KPNB1;THOC2;EIF4G3;XPO1;SENP2;UPF2;EIF3I;PHAX;SRRM1;NXF1;GEMIN7;SUMO2;PABPC4;EIF4B
prerank,Mitophagy,0.424181033904343,1.4993822509567276,0.023809523809523808,0.26951794994325307,0.89,12/68,13.83%,GABARAP;CSNK2A1;RRAS2;UBB;USP8;MFN1;BNIP3L;RAB7A;TAX1BP1;BECN1;TBK1;MAPK8
prerank,Kaposi sarcoma-associated herpesvirus infection,0.3926971198097657,1.4957176315578762,0.033707865168539325,0.2620313402226072,0.89,29/193,30.75%,GABARAP;C3;IKBKG;AKT2;UBB;CTNNB1;IFNAR1;MAPK3;PDGFB;MAP2K4;BECN1;PIK3C3;TBK1;MAPK8;IRF3;IL6ST;PIK3CB;JAK1;MAPK14;AKT1;BID;CDK4;HIF1A;CALM1;STAT1;TYK2;NRAS;PPP3CA;LYN
prerank,Sphingolipid signaling pathway,0.4171345767685762,1.4900997421135433,0.05813953488372093,0.2623716406644547,0.89,17/119,19.92%,ASAH1;AKT2;CTSD;PPP2R5C;ROCK1;PPP2R5E;PPP2R2A;MAPK3;CERS2;PPP2R5A;MAPK8;ABCC1;FYN;PIK3CB;MAPK14;AKT1;BID
prerank,Measles,0.41027403526551665,1.4869582719393277,0.047619047619047616,0.25926454967367285,0.91,17/139,26.93%,RACK1;IKBKG;CSNK2A1;AKT2;TAB2;EIF3H;IFNAR1;TBK1;MAPK8;IRF3;PIK3CB;JAK1;AKT1;BID;CDK4;STAT1;TYK2
prerank,Platelet activation,0.42957812690375446,1.4857059269750694,0.0449438202247191,0.2512693387491787,0.91,18/124,23.18%,MYL12B;GNAS;MYL12A;AKT2;ACTG1;ARHGAP35;PPP1CB;ROCK1;PPP1R12A;MAPK3;PRKCI;FYN;PIK3CB;MAPK14;RAP1B;AKT1;PRKACA;ITGB1
prerank,Hepatitis B,0.4050128034685121,1.4843696519750733,0.011764705882352941,0.24436294128188282,0.91,25/162,26.93%,DDX3X;IKBKG;AKT2;YWHAZ;TAB2;IFNAR1;MAPK3;TGFBR2;SOS1;MAP2K4;TBK1;YWHAQ;MAPK8;IRF3;PIK3CB;JAK1;MAPK14;AKT1;GRB2;BID;YWHAB;ATP6AP1;MAP2K3;STAT1;TYK2
prerank,Fluid shear stress and atherosclerosis,0.40301246533498464,1.4776470103218005,0.038461538461538464,0.2466262009897396,0.91,18/139,21.68%,CAV1;IKBKG;AKT2;ACTG1;PRKAA1;CTNNB1;MGST3;PDGFB;MGST1;HSP90B1;MAP2K4;MAPK8;SUMO1;PIK3CB;MAPK14;HSP90AA1;AKT1;PTK2
prerank,Prostate cancer,0.43782503168305154,1.477529526591757,0.06578947368421052,0.23749189724937886,0.91,13/97,19.36%,IKBKG;AKT2;ERBB2;CTNNB1;MAPK3;PDGFB;HSP90B1;SOS1;PIK3CB;IGF1R;HSP90AA1;AKT1;GRB2
prerank,ECM-receptor interaction,0.48664217690742145,1.468764776530667,0.06172839506172839,0.24625598402553187,0.92,15/88,44.79%,LAMA3;COL6A1;FN1;LAMA5;ITGB4;LAMC1;THBS1;ITGB1;HMMR;LAMB2;DAG1;LAMB1;SDC1;LAMA4;CD47
prerank,Hippo signaling pathway,0.4040620436801655,1.4594392768452589,0.034482758620689655,0.25828803536228423,0.93,26/163,31.54%,CSNK1D;ACTG1;YWHAZ;PPP1CB;CTNNB1;DVL1;PPP2R2A;DLG1;TEAD1;STK3;TGFBR2;CSNK1E;PRKCI;YWHAQ;CDH1;DVL3;YWHAB;YAP1;MOB1A;PAK1;YWHAE;FZD6;FBXW11;TEAD2;ACTB;SAV1
prerank,Drug metabolism,0.4711538885097014,1.4521614651608012,0.06329113924050633,0.26577464508293014,0.93,4/108,10.03%,UGT1A6;MGST3;TPMT;MGST1
prerank,Viral carcinogenesis,0.36119852662016133,1.4512176834107127,0.01098901098901099,0.25901254598041124,0.93,29/203,31.41%,CHD4;DDX3X;C3;IKBKG;YWHAZ;CDKN2A;ACTN1;DLG1;MAPK3;YWHAQ;IRF3;RBPJ;SP100;IL6ST;HNRNPK;PIK3CB;JAK1;GTF2H1;GRB2;YWHAB;LTBR;PRKACA;ACTN4;CDK4;YWHAE;NRAS;HDAC2;LYN;VAC14
prerank,MicroRNAs in cancer,0.3814275528375012,1.4475153618805294,0.05747126436781609,0.2565333612090078,0.94,18/310,19.36%,SHC1;ERBB2;CDKN2A;ROCK1;GLS;BMI1;RDX;MAPK3;PDGFB;SOS1;ABCC1;STMN1;ERBB3;CRK;HNRNPK;PIK3CB;THBS1;GRB2
prerank,Protein processing in endoplasmic reticulum,0.3585843061544322,1.4370057873174913,0.03260869565217391,0.27087915171064325,0.94,46/171,36.30%,UBXN6;UBE2D3;SKP1;SEC24C;TRAM1;P4HB;PRKCSH;HSP90B1;UBE2J2;HSPH1;STT3A;UBE2G1;SEC23B;UBE2D2;MAPK8;PDIA3;SEC23A;VCP;HSP90AA1;NSFL1C;DNAJC10;UBE2D1;RPN2;DERL1;SSR3;DNAJC3;SAR1B;HSPBP1;UGGT1;DNAJA2;MOGS;DERL2;SEC24D;BCAP31;HYOU1;SEC62;UBXN1;CANX;OS9;DNAJB12;SYVN1;SSR1;SAR1A;BAG1;SEC61A1;UBQLN1
prerank,Yersinia infection,0.3795563789844344,1.435576186196481,0.05555555555555555,0.2655544506793817,0.94,23/137,23.47%,IKBKG;AKT2;ACTG1;FN1;ROCK1;BAIAP2;TAB2;ARPC3;MAPK3;ARPC2;ARPC1B;MAP2K4;TBK1;MAPK8;IRF3;CRK;RPS6KA3;PIK3CB;MAPK14;AKT1;PTK2;ITGB1;ARPC5
prerank,Pathways in cancer,0.331029160288472,1.4355429130160113,0.010309278350515464,0.2579671806599708,0.94,53/531,28.03%,LAMA3;IKBKG;GNAS;AKT2;SKP1;ERBB2;TFG;FN1;CDKN2A;ROCK1;CTNNB1;LAMA5;NCOA4;MGST3;TPR;DVL1;IFNAR1;MAPK3;PDGFB;TPM3;MGST1;TGFBR2;EGLN3;HSP90B1;SOS1;MAPK8;LAMC1;IL6ST;CDH1;CRK;ELOB;CCDC6;DVL3;PIK3CB;JAK1;IGF1R;HSP90AA1;AKT1;GRB2;BID;PRKACA;PTK2;KITLG;ITGB1;GNA12;CDK4;TRAF4;HIF1A;CALM1;STAT1;PML;RALBP1;FZD6
prerank,Spinocerebellar ataxia,0.36902316799777446,1.4168464672836487,0.06741573033707865,0.2897941846033358,0.98,20/143,22.87%,PSMA5;VDAC2;AKT2;ATXN10;ATXN2L;OMA1;BECN1;PSMD8;PIK3C3;MAPK8;PSMD9;RBPJ;OPA1;PUM1;ATP2A2;PIK3CB;PSMC3;AKT1;ATXN2;PSMC6
prerank,Hepatitis C,0.3730911832576528,1.4141056457704075,0.05555555555555555,0.2898532006709535,0.98,25/157,26.93%,IKBKG;AKT2;YWHAZ;CD81;EIF3E;CLDN7;CTNNB1;PIAS1;PPP2R2A;IFNAR1;MAPK3;SOS1;TBK1;YWHAQ;IRF3;PIK3CB;JAK1;AKT1;GRB2;BID;YWHAB;CDK4;YWHAE;STAT1;TYK2
prerank,Chagas disease,0.42684429891650333,1.413908891969299,0.0975609756097561,0.2825210089317434,0.98,12/102,19.26%,C3;IKBKG;GNAS;AKT2;PPP2R2A;MAPK3;TGFBR2;MAP2K4;MAPK8;PIK3CB;MAPK14;AKT1
prerank,ErbB signaling pathway,0.4064457412458713,1.4085900459183587,0.060240963855421686,0.2873706346617164,0.99,14/85,21.68%,SHC1;NCK1;AKT2;ERBB2;MAPK3;SOS1;MAP2K4;MAPK8;ERBB3;CRK;PIK3CB;AKT1;GRB2;PTK2
prerank,Proteoglycans in cancer,0.3619084808938388,1.4063802581991776,0.06451612903225806,0.2827130995758915,0.99,28/205,25.08%,CAV1;DDX5;RRAS2;AKT2;ACTG1;ERBB2;PPP1CB;FN1;DROSHA;ROCK1;CTNNB1;RDX;PPP1R12A;FLNA;MAPK3;SOS1;ERBB3;PIK3CB;MAPK14;IGF1R;THBS1;AKT1;GRB2;PRKACA;PTK2;ITGB1;HIF1A;PAK1
prerank,Hypertrophic cardiomyopathy,0.46181485571325087,1.4012468948599643,0.08,0.28513027021435616,1.0,10/90,37.27%,ACTG1;PRKAA1;TPM3;ITGB4;LMNA;ATP2A2;ITGB1;ACTB;DAG1;TGFB2
prerank,Wnt signaling pathway,0.3740700211063279,1.389148002838502,0.025974025974025976,0.30026652558162026,1.0,18/166,30.39%,CSNK2A1;RYK;SKP1;CTNNB1;DVL1;DAAM1;CSNK1E;CSNK1A1;TBL1XR1;MAPK8;DKK1;DVL3;PRKACA;SENP2;FZD6;FBXW11;CTBP2;PPP3CA
prerank,Epithelial cell signaling in Helicobacter pylori infection,0.4084779408538221,1.3834108889293544,0.054945054945054944,0.30816974896612276,1.0,22/70,39.19%,IKBKG;ADAM17;ATP6V0E1;TJP1;F11R;MAP2K4;MAPK8;MAPK14;ATP6V1C1;PAK1;ATP6AP1;ATP6V1A;MAP3K14;LYN;MET;ATP6V0A1;RAC1;EGFR;ATP6V0C;PLCG1;ADAM10;CASP3
prerank,mRNA surveillance pathway,0.3728828791916875,1.3833596996725825,0.06818181818181818,0.30142111636646013,1.0,22/98,30.50%,BCL2L2-PABPN1;PABPN1;PPP2R5C;SAP18;PPP1CB;PCF11;PNN;PPP2R5E;PPP2R2A;RNPS1;PABPC1;PPP2R5A;NXT2;FUS;RNMT;HBS1L;CSTF1;UPF2;CPSF2;SRRM1;NXF1;CPSF6
prerank,Vascular smooth muscle contraction,0.3965491015020279,1.3791942208714758,0.045454545454545456,0.3014608180846757,1.0,8/133,9.44%,MYH14;GNAS;PPP1CB;ROCK1;CALD1;PPP1R12A;MAPK3;MYL6B
prerank,Lysine degradation,0.42865259814312134,1.378783847817345,0.06976744186046512,0.2958838363507452,1.0,17/63,37.60%,TMLHE;SETD2;NSD1;ASH1L;HADHA;ACAT2;NSD3;PLOD2;ALDH3A2;SETMAR;NSD2;KMT2E;PLOD3;KMT5A;ALDH2;DLD;ALDH7A1
prerank,Th17 cell differentiation,0.4193055105870857,1.369581520462734,0.10256410256410256,0.30488023415566573,1.0,13/107,30.39%,IKBKG;AHR;MAPK3;TGFBR2;MAPK8;IL6ST;JAK1;MAPK14;HSP90AA1;HIF1A;STAT1;TYK2;PPP3CA
prerank,Toll-like receptor signaling pathway,0.41690994961033295,1.3682688226181425,0.10714285714285714,0.3027397805786194,1.0,12/104,19.26%,IKBKG;AKT2;TAB2;IFNAR1;MAPK3;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;AKT1
prerank,Osteoclast differentiation,0.37715502093363973,1.3549946583238515,0.08791208791208792,0.32750097828988833,1.0,18/127,27.86%,IKBKG;JUND;AKT2;TAB2;IFNAR1;MAPK3;TGFBR2;MAPK8;FYN;PIK3CB;JAK1;MAPK14;AKT1;GRB2;STAT1;TYK2;MAP3K14;SQSTM1
prerank,Insulin secretion,-0.4074871770172296,-1.3529291619545343,0.1111111111111111,0.8358392144829703,0.75,5/86,11.12%,ATP1A1;ADCY7;VAMP2;ADCY6;CREB3L1
prerank,Oocyte meiosis,0.3884741105542514,1.3521526971565725,0.11235955056179775,0.32836270234753,1.0,23/129,33.64%,SKP1;PPP2R5C;YWHAZ;PPP1CB;PPP2R5E;MAPK3;PPP2R5A;YWHAQ;SLK;RPS6KA3;MAPK14;IGF1R;YWHAB;PRKACA;ANAPC2;CALM1;YWHAE;FBXW11;PPP3CA;ANAPC13;ANAPC7;CDC16;ANAPC5
prerank,Influenza A,0.3574717770816578,1.3394322433243961,0.08602150537634409,0.34966871283487416,1.0,23/172,27.11%,IKBKG;BCL2L2-PABPN1;AKT2;ACTG1;RAB11A;PABPN1;IFNAR1;MAPK3;NXT2;TBK1;IRF3;PIK3CB;JAK1;AKT1;BID;DNAJC3;CDK4;KPNA1;XPO1;CALCOCO2;STAT1;TYK2;PML
prerank,Coronavirus disease,0.33758719894960904,1.335965138312031,0.07291666666666667,0.35028695096791385,1.0,29/232,17.44%,C3;IKBKG;RPL32;RPL11;RPL8;RPL37;RPL17;RPL15;RPL29;RPL13;ADAM17;RPL4;TAB2;RPL22;IFNAR1;MAPK3;RPSA;TBK1;MAPK8;RPLP0;RPS20;RPS27;IRF3;RPL41;IL6ST;PIK3CB;RPL28;JAK1;MAPK14
prerank,Gastric cancer,0.3733795058760835,1.333091476648659,0.06896551724137931,0.34897489273312726,1.0,14/149,19.36%,SHC1;AKT2;ERBB2;CTNNB1;DVL1;MAPK3;TGFBR2;SOS1;CSNK1A1;CDH1;DVL3;PIK3CB;AKT1;GRB2
prerank,Various types of N-glycan biosynthesis,0.4511937749934849,1.327892741309901,0.09859154929577464,0.354990077587294,1.0,8/39,22.17%,HEXB;STT3A;ALG13;ALG2;ALG11;RPN2;ALG12;FUT8
prerank,NOD-like receptor signaling pathway,0.36873897399989836,1.3252710724438237,0.11494252873563218,0.3520067770470972,1.0,21/181,27.84%,GABARAP;NAMPT;IKBKG;VDAC2;TAB2;IFI16;MFN1;IFNAR1;MAPK3;TBK1;MAPK8;DNM1L;IRF3;JAK1;MAPK14;HSP90AA1;TANK;YWHAE;STAT1;TYK2;RIPK2
prerank,Fatty acid degradation,0.4453400843937533,1.32388379066412,0.058823529411764705,0.34852842038792703,1.0,12/43,38.29%,ACADM;HADHA;ACAT2;ACADVL;ALDH3A2;ACAA2;HADHB;ACSL4;CPT2;ALDH2;ALDH7A1;ECI2
prerank,Thyroid cancer,0.45646316105211776,1.323341347423189,0.10666666666666667,0.34300493483275113,1.0,8/37,16.23%,TFG;CTNNB1;NCOA4;TPR;MAPK3;TPM3;CDH1;CCDC6
prerank,Human immunodeficiency virus 1 infection,0.34364925024657983,1.3118348146656071,0.1111111111111111,0.3578083128556981,1.0,33/212,34.10%,IKBKG;AKT2;SKP1;AP1B1;TAB2;MAPK3;CUL5;B2M;CFL1;TBK1;MAPK8;PDIA3;CUL4B;AP1G1;IRF3;CRK;ELOB;PIK3CB;MAPK14;AKT1;BID;PTK2;PAK1;CALM1;MAP2K3;AP1G2;FBXW11;NRAS;CUL4A;PPP3CA;DCAF1;RAC1;APOBEC3B
prerank,Insulin signaling pathway,0.3584079314551369,1.308190592955041,0.12790697674418605,0.35669254109721493,1.0,20/137,28.89%,SHC1;AKT2;PRKAA1;PPP1CB;MAPK3;MKNK2;SOS1;PRKCI;MAPK8;INPPL1;CRK;PIK3CB;AKT1;GRB2;PRKACA;PYGB;CALM1;EXOC7;FBP1;NRAS
prerank,MAPK signaling pathway,0.33368586944274814,1.295136459430937,0.06521739130434782,0.3754534774903928,1.0,52/294,39.77%,IKBKG;JUND;RRAS2;AKT2;ERBB2;LAMTOR3;RASA1;TAB2;FLNA;MAPK3;MKNK2;PDGFB;MAP3K13;STK3;TGFBR2;SOS1;MAP2K4;MAPK8;STMN1;ERBB3;TAOK3;CRK;RPS6KA3;MAPK14;IGF1R;RAP1B;AKT1;GRB2;PPM1A;PRKACA;KITLG;GNA12;PAK1;MAP3K2;MAP2K3;MAP3K14;NRAS;NF1;RAP1A;PPP3CA;MET;PPM1B;RAC1;EGFR;PDGFC;MAPKAPK5;TGFB2;ATF2;ARRB2;MKNK1;CASP3;MAP3K20
prerank,Phagosome,0.3640122014473717,1.2933930554777693,0.11627906976744186,0.37261224773575424,1.0,23/152,36.85%,C3;ACTG1;RAB5A;DYNC1I2;TUBA4A;ATP6V0E1;RAB7A;PIK3C3;THBS1;ATP6V1C1;STX18;ITGB1;DYNC1H1;ATP6AP1;ATP6V1A;ACTB;SEC22B;ATP6V0A1;CANX;RAC1;NCF2;SEC61A1;ATP6V0C
prerank,Retrograde endocannabinoid signaling,-0.2834799186108663,-1.2909618119373376,0.09090909090909091,0.5817735501687634,0.84,9/148,9.93%,NDUFA13;NDUFA1;NDUFA11;NDUFB7;ADCY7;NDUFB2;NDUFA2;NDUFS7;ADCY6
prerank,Cell cycle,0.37788177093806957,1.2904150828549104,0.13253012048192772,0.3736663512990129,1.0,22/124,37.91%,SKP1;YWHAZ;CDKN2A;ORC4;STAG2;YWHAQ;YWHAB;CDK4;ANAPC2;YWHAE;FZR1;HDAC2;ANAPC13;ANAPC7;CDC16;ANAPC5;ORC3;BUB3;TGFB2;ANAPC11;STAG1;CCND1
prerank,Cardiac muscle contraction,-0.3557963246433196,-1.2893172065934628,0.1111111111111111,0.3903037741638539,0.84,11/87,20.14%,COX5B;ATP1A1;COX7B2;COX7C;TPM4;COX5A;COX6A1;UQCRH;COX6B1;COX7B;UQCRQ
prerank,Legionellosis,0.4460445197524086,1.2841516938649002,0.1527777777777778,0.3827083588149235,1.0,14/57,40.25%,C3;EEF1A1;RAB1B;RAB1A;VCP;HBS1L;HSPD1;SAR1B;CLK1;SEC22B;SAR1A;BCL2L13;CASP3;EEF1G
prerank,Dilated cardiomyopathy,0.3957163967175761,1.2799185771876498,0.1375,0.3855019114748223,1.0,8/96,23.18%,GNAS;ACTG1;TPM3;ITGB4;LMNA;ATP2A2;PRKACA;ITGB1
prerank,Fc gamma R-mediated phagocytosis,0.3682157234616848,1.2767527071684832,0.12987012987012986,0.38458138241902656,1.0,22/97,37.41%,AKT2;DNM2;ARPC3;MAPK3;ASAP1;ARPC2;ARPC1B;CFL1;INPPL1;CRK;PIK3CB;AKT1;WASF1;ARPC5;PAK1;ACTR2;LYN;RAC1;CFL2;ASAP2;PLCG1;ACTR3
prerank,Small cell lung cancer,0.3722316019417543,1.2728376241797668,0.17073170731707318,0.38658130193880746,1.0,12/92,24.11%,LAMA3;IKBKG;AKT2;FN1;LAMA5;LAMC1;PIK3CB;AKT1;PTK2;ITGB1;CDK4;TRAF4
prerank,Glutamatergic synapse,0.42323111581953193,1.2705321120136686,0.1527777777777778,0.384666477064531,1.0,4/114,8.36%,SLC38A2;GNAS;GLS;MAPK3
prerank,Glucagon signaling pathway,0.3671610385359575,1.268757120284881,0.15,0.38247767896358703,1.0,13/107,32.18%,GNAS;AKT2;PRKAA1;PPP4R3B;LDHA;AKT1;PRKACA;PYGB;CALM1;FBP1;PPP4C;PPP3CA;PPARA
prerank,Cell adhesion molecules,0.4117595784464986,1.268356129500642,0.1095890410958904,0.3779110385073875,1.0,8/148,25.45%,ALCAM;NRCAM;CLDN7;F11R;CDH1;ITGB1;MPZL1;GLG1
prerank,AMPK signaling pathway,0.3414030595655338,1.2673220093232556,0.12359550561797752,0.3750791470043605,1.0,13/120,19.26%,AKT2;PRKAA1;PPP2R5C;PPP2R5E;PPP2R2A;RAB10;PPP2R5A;ADIPOR1;RAB14;PIK3CB;STRADB;IGF1R;AKT1
prerank,Toxoplasmosis,0.37154159378537877,1.2651027978364522,0.1411764705882353,0.3742250408249629,1.0,15/112,26.93%,LAMA3;IKBKG;AKT2;TAB2;LAMA5;MAPK3;MAPK8;LAMC1;JAK1;MAPK14;AKT1;ITGB1;MAP2K3;STAT1;TYK2
prerank,Vibrio cholerae infection,0.39430705253745524,1.2597274112727306,0.14942528735632185,0.38353277714725653,1.0,15/50,37.30%,GNAS;ACTG1;ATP6V0E1;TJP1;TJP2;ATP6V1C1;KDELR3;PRKACA;ATP6AP1;ATP6V1A;ACTB;ATP6V0A1;SEC61A1;ATP6V0C;PLCG1
prerank,FoxO signaling pathway,0.3426103203631825,1.2578707257363615,0.13953488372093023,0.38381694355503226,1.0,13/131,19.36%,GABARAP;AKT2;PRKAA1;MAPK3;TGFBR2;CSNK1E;SOS1;MAPK8;PIK3CB;MAPK14;IGF1R;AKT1;GRB2
prerank,Transcriptional misregulation in cancer,0.3472312728447744,1.2567393696227418,0.15384615384615385,0.3815135845480508,1.0,17/192,27.11%,DDX5;TAF15;PRCC;BMI1;SIN3A;CDK9;TGFBR2;MLF1;IGF1R;MEN1;EWSR1;FUS;PTK2;FUT8;NCOR1;NSD2;PML
prerank,Dopaminergic synapse,0.3824349885158777,1.2558597584854683,0.10975609756097561,0.37777432650379306,1.0,13/132,25.69%,GNAS;AKT2;PPP2R5C;PPP1CB;PPP2R5E;PPP2R2A;PPP2R5A;MAPK8;MAPK14;AKT1;PRKACA;COMT;CALM1
prerank,Lysosome,0.34658592114613695,1.2489931285731215,0.18604651162790697,0.3874320530434263,1.0,18/128,26.77%,ASAH1;CTSD;PPT1;AP1B1;AP3D1;LITAF;AP3S1;HEXB;AP3M1;AP3B1;CD164;AP1G1;NPC1;IDS;CTSZ;CLTC;ATP6AP1;AP1G2
prerank,Relaxin signaling pathway,0.3544524722919265,1.2488058220649865,0.1724137931034483,0.3829838401249906,1.0,13/129,20.73%,SHC1;GNAS;AKT2;MAPK3;TGFBR2;SOS1;MAP2K4;MAPK8;PIK3CB;MAPK14;AKT1;GRB2;PRKACA
prerank,IL-17 signaling pathway,0.41156730874365755,1.2437438340995681,0.25,0.3875760263072849,1.0,11/94,24.11%,IKBKG;JUND;TAB2;MAPK3;HSP90B1;TBK1;MAPK8;MAPK14;HSP90AA1;TRAF3IP2;TRAF4
prerank,Ras signaling pathway,0.34872578458274345,1.242633695700468,0.13636363636363635,0.3860816202773604,1.0,32/232,35.97%,SHC1;IKBKG;RRAS2;AKT2;RAB5A;RASA1;BRAP;MAPK3;PDGFB;AFDN;SOS1;TBK1;MAPK8;PIK3CB;IGF1R;RAP1B;AKT1;GRB2;PRKACA;KITLG;PAK1;CALM1;RALBP1;SYNGAP1;NRAS;NF1;RAP1A;MET;RAC1;RASAL2;EGFR;PDGFC
prerank,Estrogen signaling pathway,0.35999405408205043,1.2424242878141163,0.14285714285714285,0.38139597395615554,1.0,13/137,20.73%,SHC1;GNAS;AKT2;CTSD;MAPK3;HSP90B1;SOS1;EBAG9;PIK3CB;HSP90AA1;AKT1;GRB2;PRKACA
prerank,Epstein-Barr virus infection,0.3332152008143587,1.2402232052423627,0.07058823529411765,0.3826489412774581,1.0,25/202,27.26%,IKBKG;AKT2;TAB2;IFNAR1;SIN3A;B2M;MAP2K4;PSMD8;TBK1;MAPK8;PDIA3;IRF3;RBPJ;PIK3CB;JAK1;MAPK14;PSMC3;AKT1;BID;PSMC6;CDK4;MAP2K3;STAT1;TYK2;MAP3K14
prerank,GnRH signaling pathway,0.37473810699517884,1.2368240350126052,0.2,0.3852408501983592,1.0,13/93,28.89%,GNAS;MMP14;MAPK3;SOS1;MAP2K4;MAPK8;MAPK14;GRB2;PRKACA;CALM1;MAP3K2;MAP2K3;NRAS
prerank,Ribosome biogenesis in eukaryotes,0.37766220523455696,1.2328534275352863,0.13580246913580246,0.3904763069960986,1.0,11/108,33.53%,CSNK2A1;DROSHA;POP4;FBL;NXT2;REXO2;FCF1;XPO1;NXF1;SNU13;LSG1
prerank,Tuberculosis,0.34221524754664595,1.2293132008040366,0.14942528735632185,0.39398283654899147,1.0,20/180,27.84%,C3;AKT2;CTSD;RAB5A;RAB7A;MAPK3;PIK3C3;MAPK8;JAK1;MAPK14;BCL10;AKT1;BID;HSPD1;NFYC;CALM1;ATP6AP1;NFYA;STAT1;RIPK2
prerank,RNA degradation,0.35837554745548866,1.2291144552430542,0.16455696202531644,0.38961197763855554,1.0,20/79,36.21%,CNOT1;ENO1;PABPC1;PAN3;TTC37;DDX6;CNOT9;MTREX;HSPD1;DHX36;CNOT3;CNOT2;CNOT7;DIS3;TENT4A;PABPC4;CNOT4;CNOT6;WDR61;EDC3
prerank,Cytosolic DNA-sensing pathway,0.40762425802923796,1.2265637983334143,0.24615384615384617,0.39043540229182494,1.0,5/63,15.46%,IKBKG;POLR2F;TBK1;POLR2H;IRF3
prerank,T cell receptor signaling pathway,0.3604751882060918,1.2185239052819963,0.20224719101123595,0.40440600439282187,1.0,18/104,30.39%,IKBKG;NCK1;AKT2;DLG1;MAPK3;SOS1;MAPK8;FYN;PIK3CB;MAPK14;BCL10;AKT1;GRB2;CDK4;PAK1;MAP3K14;NRAS;PPP3CA
prerank,Inositol phosphate metabolism,0.36230456930889476,1.2184074249229724,0.20512820512820512,0.4001933196127091,1.0,12/73,28.78%,ITPK1;PLCD3;TPI1;PI4KB;PIK3C3;INPPL1;PIK3CB;MTMR2;INPP4B;MTMR6;PIK3C2A;OCRL
prerank,Human T-cell leukemia virus 1 infection,0.31381703061990196,1.2072792115762365,0.16853932584269662,0.4206801709320252,1.0,39/219,40.01%,IKBKG;VDAC2;AKT2;CDKN2A;DLG1;MAPK3;B2M;TGFBR2;MAP2K4;MAPK8;GPS2;PIK3CB;JAK1;AKT1;LTBR;PRKACA;CDK4;ANAPC2;TRRAP;XPO1;MAP3K14;NRAS;TSPO;PPP3CA;VAC14;ANAPC7;CANX;CDC16;ANAPC5;XIAP;BUB3;TGFB2;ATF2;ANAPC11;CCND1;RANBP3;FDPS;BAX;SMAD3
prerank,Oxidative phosphorylation,-0.23892567514170138,-1.2065138494133711,0.16666666666666666,0.4657870512427125,0.92,14/133,9.48%,NDUFA13;NDUFA1;COX5B;ATP5ME;NDUFA11;NDUFB7;ATP5F1E;COX7B2;ATP6V1G1;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7
prerank,AGE-RAGE signaling pathway in diabetic complications,0.3604078518616661,1.2055703508630247,0.2125,0.4196244748422038,1.0,20/100,40.01%,AKT2;FN1;DIAPH1;MAPK3;PLCD3;TGFBR2;MAPK8;PIK3CB;MAPK14;AKT1;CDK4;STAT1;NRAS;RAC1;TGFB2;PLCG1;CCND1;CASP3;BAX;SMAD3
prerank,Adrenergic signaling in cardiomyocytes,0.3404107840354295,1.2033836520415249,0.20930232558139536,0.4197026317568699,1.0,13/150,20.73%,GNAS;AKT2;PPP2R5C;PPP1CB;PPP2R5E;PPP2R2A;MAPK3;TPM3;PPP2R5A;ATP2A2;MAPK14;AKT1;PRKACA
prerank,Ferroptosis,0.4323083319112373,1.2019230075866123,0.21333333333333335,0.41868051100786147,1.0,8/41,32.64%,FTH1;VDAC2;NCOA4;GCLM;SLC7A11;GCLC;SLC39A8;ACSL4
prerank,Breast cancer,0.352945563297543,1.1945800427001332,0.21176470588235294,0.43011780362807683,1.0,13/147,19.36%,SHC1;AKT2;ERBB2;CTNNB1;DVL1;MAPK3;SOS1;CSNK1A1;DVL3;PIK3CB;IGF1R;AKT1;GRB2
prerank,Leishmaniasis,0.4052394151701327,1.1910588100284272,0.25,0.4315154411325488,1.0,8/77,26.91%,C3;EEF1A1;TAB2;MAPK3;JAK1;MAPK14;ITGB1;STAT1
prerank,Endometrial cancer,0.3571701819756346,1.1818955681905319,0.21951219512195122,0.44695060032256134,1.0,9/58,19.36%,AKT2;ERBB2;CTNNB1;MAPK3;SOS1;CDH1;PIK3CB;AKT1;GRB2
prerank,Cytokine-cytokine receptor interaction,-0.25695411610202684,-1.1784609037729035,0.2,0.44332617367290583,0.95,11/295,22.06%,INHBA;CSF1;TNFSF10;ACVR2A;BMP8B;IL11;IFNGR2;TNFSF12;IL17RC;IL13RA1;CXCL16
prerank,Oxytocin signaling pathway,0.33161496490459363,1.1748468092166566,0.19047619047619047,0.4582039105589073,1.0,8/154,9.44%,GNAS;ACTG1;PRKAA1;PPP1CB;ROCK1;PPP1R12A;MAPK3;MYL6B
prerank,Prolactin signaling pathway,0.3736290249449672,1.167274449794547,0.2558139534883721,0.4688778768342676,1.0,9/70,19.36%,SHC1;AKT2;MAPK3;SOS1;MAPK8;PIK3CB;MAPK14;AKT1;GRB2
prerank,Gap junction,0.3693537980401764,1.1655780803549198,0.24050632911392406,0.4679895015171112,1.0,7/88,10.56%,CSNK1D;GNAS;TUBA4A;MAPK3;TJP1;PDGFB;SOS1
prerank,B cell receptor signaling pathway,0.36942675436768146,1.161523249369661,0.24390243902439024,0.47256388024561974,1.0,10/81,19.36%,IKBKG;AKT2;CD81;MAPK3;SOS1;INPPL1;PIK3CB;BCL10;AKT1;GRB2
prerank,Human cytomegalovirus infection,0.3002707624909152,1.160071406551969,0.23863636363636365,0.4712072158174542,1.0,24/225,25.69%,IKBKG;GNAS;AKT2;CDKN2A;ROCK1;CTNNB1;MAPK3;B2M;SOS1;TBK1;PDIA3;IRF3;CRK;PIK3CB;JAK1;MAPK14;AKT1;GRB2;BID;PRKACA;PTK2;GNA12;CDK4;CALM1
prerank,Long-term potentiation,0.3992787451089365,1.1573967095090927,0.31645569620253167,0.4713228505814562,1.0,9/67,30.39%,PPP1CB;MAPK3;RPS6KA3;RAP1B;PRKACA;CALM1;NRAS;RAP1A;PPP3CA
prerank,"Growth hormone synthesis, secretion and action",0.3211248551788496,1.1539582136497475,0.21176470588235294,0.4745189396468223,1.0,17/119,28.89%,SHC1;GNAS;AKT2;MAPK3;SOS1;MAP2K4;MAPK8;CRK;PIK3CB;MAPK14;AKT1;GRB2;PRKACA;PTK2;MAP2K3;STAT1;NRAS
prerank,RIG-I-like receptor signaling pathway,0.3755802335161483,1.1521349673233987,0.2716049382716049,0.4736189217449399,1.0,8/70,22.25%,DDX3X;IKBKG;AZI2;TBK1;MAPK8;IRF3;MAPK14;TANK
prerank,Necroptosis,0.31312564028581286,1.1520026211897194,0.27058823529411763,0.4691728735991325,1.0,19/159,27.86%,FTH1;VDAC2;CHMP2B;IFNAR1;PPID;SPATA2;CHMP3;CHMP4C;MAPK8;DNM1L;CHMP5;JAK1;HSP90AA1;BID;CHMP2A;PYGB;STAT1;TYK2;SQSTM1
prerank,Pathways of neurodegeneration,0.2674471983882428,1.148188455375677,0.20833333333333334,0.47240507337275756,1.0,60/475,26.44%,GABARAP;PSMA5;APP;CSNK2A1;VDAC2;UBB;UCHL1;RAB5A;UQCRC1;GPX8;CTNNB1;GPX3;CHMP2B;MFN1;TUBA4A;DVL1;MAPK3;NDUFB5;SDHC;ATXN2L;PPID;CSNK1E;NDUFS6;UBE2J2;ACTR10;BECN1;UBE2G1;PSMD8;CSNK1A1;PIK3C3;TBK1;MAPK8;RAB1A;DKK1;IFT57;PSMD9;DVL3;ATP5PB;ATP2A2;MAPK14;VCP;NDUFA5;UQCRC2;FUS;PSMC3;DCTN2;DERL1;BID;SDHA;NDUFA10;ATXN2;TANK;PSMC6;PARK7;DCTN6;SDHB;CALM1;HTRA2;MAP2K3;NDUFB6
prerank,Chronic myeloid leukemia,0.3295703866028567,1.1436577597552655,0.2857142857142857,0.4776951400527234,1.0,11/76,19.36%,SHC1;IKBKG;AKT2;CDKN2A;MAPK3;TGFBR2;SOS1;CRK;PIK3CB;AKT1;GRB2
prerank,"Valine, leucine and isoleucine degradation",0.3628388036224211,1.1395867124688854,0.2441860465116279,0.48236156461806506,1.0,15/48,44.22%,MCCC2;ACADM;HADHA;ACAT2;ALDH3A2;ACAA2;HADHB;IVD;ALDH2;DLD;ALDH7A1;BCAT2;HSD17B10;BCAT1;HMGCS1
prerank,Glioma,0.33922052847498074,1.1366394092591698,0.2875,0.4854858442457749,1.0,12/75,25.69%,SHC1;AKT2;CDKN2A;MAPK3;PDGFB;SOS1;PIK3CB;IGF1R;AKT1;GRB2;CDK4;CALM1
prerank,Chemical carcinogenesis,0.308918147218136,1.1359787526406366,0.2619047619047619,0.48237119328528705,1.0,19/239,26.25%,UGT1A6;GNAS;AKT2;AHR;MGST3;MAPK3;MGST1;HSP90B1;SOS1;AKR1C2;RPS6KA3;PIK3CB;HSP90AA1;AKT1;GRB2;PRKACA;KPNB1;KPNA1;PTGES3
prerank,Choline metabolism in cancer,0.33989284464774044,1.135467047099564,0.23170731707317074,0.4788027216794913,1.0,12/98,20.71%,DGKZ;AKT2;MAPK3;PDGFB;SLC44A2;SOS1;MAPK8;SLC44A1;PIK3CB;AKT1;GRB2;WASF1
prerank,"Parathyroid hormone synthesis, secretion and action",0.33160981183063676,1.1236660236327864,0.3333333333333333,0.5019063624881676,1.0,6/106,8.36%,SLC9A3R1;NACA;JUND;GNAS;MMP14;MAPK3
prerank,Pancreatic cancer,0.32641526235389934,1.1183824122731836,0.32432432432432434,0.5100587095838276,1.0,19/76,40.01%,IKBKG;AKT2;ERBB2;CDKN2A;MAPK3;TGFBR2;MAPK8;PIK3CB;JAK1;AKT1;CDK4;STAT1;RALBP1;RAC1;EGFR;TGFB2;CCND1;BAX;SMAD3
prerank,Fc epsilon RI signaling pathway,0.3516975766665138,1.1151244583459592,0.2727272727272727,0.5114083224218217,1.0,10/68,19.36%,AKT2;MAPK3;SOS1;MAP2K4;MAPK8;FYN;PIK3CB;MAPK14;AKT1;GRB2
prerank,Rap1 signaling pathway,0.29766838866898665,1.1118800927080241,0.28888888888888886,0.5139163541132863,1.0,30/210,35.97%,GNAS;AKT2;ACTG1;CTNNB1;MAPK3;PDGFB;AFDN;PRKCI;CDH1;CRK;CTNND1;PIK3CB;MAPK14;IGF1R;THBS1;RAP1B;AKT1;ENAH;KITLG;ITGB1;CALM1;MAP2K3;NRAS;PRKD3;RAP1A;ACTB;MET;RAC1;EGFR;PDGFC
prerank,JAK-STAT signaling pathway,0.3203086412424149,1.1091230049769008,0.2564102564102564,0.5163807678622907,1.0,11/162,19.36%,AKT2;PIAS1;IFNAR1;PDGFB;SOS1;PTPN2;IL6ST;PIK3CB;JAK1;AKT1;GRB2
prerank,Th1 and Th2 cell differentiation,0.3729694920903977,1.1075886358327538,0.32857142857142857,0.5156079746400022,1.0,9/92,30.39%,IKBKG;MAPK3;MAPK8;RBPJ;JAK1;MAPK14;STAT1;TYK2;PPP3CA
prerank,Thyroid hormone signaling pathway,0.29793920680456587,1.1074591277185437,0.3333333333333333,0.511297051049754,1.0,23/121,39.13%,AKT2;ACTG1;MED17;CTNNB1;MAPK3;PLCD3;SIN3A;ATP2A2;PIK3CB;AKT1;PRKACA;HIF1A;NCOR1;STAT1;NRAS;HDAC2;ACTB;MED13L;MED4;MED24;PLCG1;CCND1;MED14
prerank,HIF-1 signaling pathway,0.31534137109728005,1.1045582545523243,0.34523809523809523,0.511532126039896,1.0,12/109,20.38%,AKT2;ERBB2;ENO1;MAPK3;MKNK2;EGLN3;ELOB;PIK3CB;IGF1R;LDHA;AKT1;LTBR
prerank,Adipocytokine signaling pathway,0.3469435692733183,1.0904681721499463,0.38095238095238093,0.539507745036967,1.0,6/69,19.26%,IKBKG;AKT2;PRKAA1;MAPK8;ADIPOR1;AKT1
prerank,Neutrophil extracellular trap formation,0.31914372431965154,1.0885958634065542,0.28888888888888886,0.5398781434800789,1.0,9/189,19.26%,C3;VDAC2;AKT2;ACTG1;CLCN3;MAPK3;PIK3CB;MAPK14;AKT1
prerank,Notch signaling pathway,0.3397435460015491,1.087966310816577,0.375,0.537086906446834,1.0,7/59,16.28%,LFNG;ADAM17;DVL1;DTX4;NUMBL;RBPJ;DVL3
prerank,Signaling pathways regulating pluripotency of stem cells,0.32613199795013137,1.0809019364657446,0.4,0.5478725539830063,1.0,13/143,19.36%,AKT2;CTNNB1;DVL1;BMI1;MAPK3;IL6ST;DVL3;PIK3CB;JAK1;MAPK14;IGF1R;AKT1;GRB2
prerank,Spliceosome,0.29055227636335085,1.0776031720198422,0.3493975903614458,0.5499006139932971,1.0,28/150,25.83%,HNRNPU;DDX5;BUD31;SNRPA;SRSF3;SF3B1;DDX46;ISY1-RAB43;SF3A1;AQR;RBM22;DHX15;SNRPD3;SART1;SNRNP70;HNRNPK;PRPF38B;TXNL4A;FUS;PLRG1;PRPF40A;PUF60;RP9;SMNDC1;THOC2;HNRNPC;U2SURP;SNRPE
prerank,Acute myeloid leukemia,0.35162878922089713,1.0735063568227998,0.31645569620253167,0.5545223143489714,1.0,7/67,19.36%,IKBKG;AKT2;MAPK3;SOS1;PIK3CB;AKT1;GRB2
prerank,Herpes simplex virus 1 infection,0.2769377854768655,1.067155485144924,0.3617021276595745,0.5649994623977063,1.0,22/498,19.92%,C3;IKBKG;AKT2;PPP1CB;ZNF480;TAB2;SRSF3;IFNAR1;B2M;TBK1;PDIA3;ZNF761;IRF3;ZNF766;SP100;PIK3CB;JAK1;ZNF583;ZNF768;ZNF600;AKT1;BID
prerank,Axon guidance,0.28729954203045616,1.0611975380862988,0.3707865168539326,0.5730821488542055,1.0,26/182,35.95%,MYL12B;RYK;MYL12A;NCK1;NTN4;ROCK1;RASA1;MAPK3;CFL1;FYN;PIK3CB;ENAH;SEMA4B;PTK2;ITGB1;PAK1;PLXNA3;NRAS;PPP3CA;SEMA3C;ABLIM3;MET;ABLIM1;RAC1;CFL2;SEMA7A
prerank,Phosphatidylinositol signaling system,0.3158073104542614,1.0570653975728752,0.4155844155844156,0.5772352943666523,1.0,15/97,31.38%,ITPK1;DGKZ;PLCD3;PI4KB;CDS1;PIK3C3;INPPL1;PIK3CB;MTMR2;INPP4B;CALM1;MTMR6;PIK3C2A;OCRL;PPIP5K2
prerank,Synaptic vesicle cycle,0.3560992486254725,1.053832071684846,0.45121951219512196,0.5807971447344843,1.0,9/78,26.38%,AP2M1;DNM2;AP2B1;ATP6V0E1;ATP6V1C1;CLTC;AP2S1;STX3;ATP6V1A
prerank,Lipid and atherosclerosis,0.2745916647677888,1.0478624115459225,0.39080459770114945,0.5900493103085819,1.0,24/215,30.75%,IKBKG;AKT2;TAB2;MAPK3;HSP90B1;MAP2K4;TBK1;MAPK8;IRF3;PIK3CB;MAPK14;HSP90AA1;RAP1B;AKT1;BID;HSPD1;PTK2;TANK;CALM1;MAP2K3;NRAS;RAP1A;PPP3CA;LYN
prerank,Pertussis,0.3530243901708079,1.0380049096106803,0.4266666666666667,0.6078839146636769,1.0,8/76,25.69%,C3;MAPK3;CFL1;MAPK8;IRF3;MAPK14;ITGB1;CALM1
prerank,Vasopressin-regulated water reabsorption,0.31934363398175025,1.0348647955803216,0.4084507042253521,0.6094157462298303,1.0,9/44,24.59%,GNAS;RAB11A;RAB5A;DYNC1I2;ARHGDIB;DCTN2;PRKACA;DCTN6;DYNC1H1
prerank,TNF signaling pathway,0.30571247164233484,1.032794506188994,0.40476190476190477,0.6091377909070997,1.0,11/112,19.26%,IKBKG;AKT2;MMP14;TAB2;MAPK3;MAP2K4;MAPK8;DNM1L;PIK3CB;MAPK14;AKT1
prerank,Neurotrophin signaling pathway,0.29729143223264254,1.0308718219725506,0.47619047619047616,0.6086107090197269,1.0,15/119,19.36%,SHC1;AKT2;MAGED1;PRDM4;MAPK3;SOS1;MAPK8;CRK;RPS6KA3;PIK3CB;MAPK14;ARHGDIB;RAP1B;AKT1;GRB2
prerank,Calcium signaling pathway,0.29905012153783606,1.0269397293581777,0.45,0.60951618468199,1.0,18/240,39.11%,VDAC2;GNAS;ERBB2;PLCD3;PDGFB;ERBB3;MST1R;ATP2A2;PTAFR;PRKACA;CALM1;PPP3CA;MET;EGFR;PDGFC;MCU;PLCG1;ASPH
prerank,Cellular senescence,0.27314193447991286,1.023461646457994,0.4777777777777778,0.6125710442537394,1.0,22/156,30.39%,VDAC2;RRAS2;AKT2;PPP1CB;CDKN2A;HUS1;MAPK3;TGFBR2;PPID;NBN;PIK3CB;MAPK14;AKT1;RBBP4;TRAF3IP2;CDK4;CALM1;MAP2K3;SQSTM1;FBXW11;NRAS;PPP3CA
prerank,Serotonergic synapse,0.3752578576703686,1.0208339727791391,0.49333333333333335,0.6126083549721185,1.0,3/113,8.36%,APP;GNAS;MAPK3
prerank,cAMP signaling pathway,0.2825396767513839,1.020545985358181,0.45977011494252873,0.6087105523961671,1.0,14/216,20.73%,GNAS;RRAS2;AKT2;PPP1CB;ROCK1;PPP1R12A;MAPK3;AFDN;MAPK8;ATP2A2;PIK3CB;RAP1B;AKT1;PRKACA
prerank,Alcoholism,0.3080489666571846,1.0163210511069176,0.42168674698795183,0.6141461256708125,1.0,11/186,30.66%,SHC1;GNAS;PPP1CB;MAPK3;SOS1;GRB2;PRKACA;CALM1;SLC29A1;NRAS;HDAC2
prerank,Phospholipase D signaling pathway,0.28787943983576053,1.0142210613121692,0.4942528735632184,0.6132018105723294,1.0,15/148,23.80%,SHC1;DGKZ;GNAS;RRAS2;AKT2;DNM2;MAPK3;PDGFB;SOS1;FYN;PIK3CB;AKT1;GRB2;KITLG;GNA12
prerank,Non-alcoholic fatty liver disease,-0.20562927475290457,-1.011463933504933,0.4166666666666667,0.8603866216630869,1.0,14/155,10.28%,NDUFA13;NDUFA1;COX5B;NDUFA11;NDUFB7;COX7B2;AKT3;PIK3CA;NDUFB2;COX7C;NDUFA2;COX5A;NDUFS7;NR1H3
prerank,C-type lectin receptor signaling pathway,0.31116053010985817,1.0108195864521903,0.44047619047619047,0.615720173739408,1.0,15/104,30.39%,IKBKG;RRAS2;AKT2;MAPK3;MAPK8;PIK3CB;MAPK14;BCL10;AKT1;PAK1;CALM1;STAT1;MAP3K14;NRAS;PPP3CA
prerank,Chemokine signaling pathway,0.2776967992338664,1.0084517709674947,0.4659090909090909,0.6146188001513251,1.0,18/192,30.75%,SHC1;IKBKG;AKT2;ROCK1;MAPK3;SOS1;CRK;PIK3CB;RAP1B;AKT1;GRB2;PRKACA;PTK2;PAK1;STAT1;NRAS;RAP1A;LYN
prerank,Apelin signaling pathway,0.2842177177852479,1.0017082155355623,0.4444444444444444,0.6224694201887749,1.0,10/137,20.73%,GABARAP;RRAS2;AKT2;PRKAA1;MAPK3;BECN1;PIK3C3;CDH1;AKT1;PRKACA
prerank,Renal cell carcinoma,0.2894296405085528,1.0009365559026049,0.4418604651162791,0.6199226972179603,1.0,18/69,33.90%,AKT2;PRCC;MAPK3;PDGFB;EGLN3;SOS1;CRK;ELOB;PIK3CB;RAP1B;AKT1;GRB2;HIF1A;PAK1;NRAS;RAP1A;MET;RAC1
prerank,Cysteine and methionine metabolism,0.35706605617623255,0.9958983519417433,0.44155844155844154,0.6265356509965554,1.0,8/50,26.03%,GCLM;MAT2B;TST;AHCY;AHCYL1;LDHA;GCLC;MPST
prerank,Inflammatory mediator regulation of TRP channels,0.3174623921258235,0.993645825971759,0.46835443037974683,0.6262419951842368,1.0,8/98,26.27%,GNAS;PPP1CB;MAPK8;PIK3CB;MAPK14;PRKACA;CALM1;MAP2K3
prerank,Insulin resistance,0.31940755292806156,0.9914493279091461,0.41975308641975306,0.6256446931616497,1.0,11/108,24.92%,AKT2;PRKAA1;PPP1CB;GFPT1;MAPK8;RPS6KA3;PIK3CB;OGA;AKT1;OGT;PYGB
prerank,Amyotrophic lateral sclerosis,0.23216640293881866,0.9875302336922192,0.4583333333333333,0.6307850659527894,1.0,45/364,24.09%,GABARAP;PSMA5;ACTG1;RAB5A;UQCRC1;GPX8;GPX3;CHMP2B;SRSF3;MATR3;TUBA4A;TPR;NDUFB5;SDHC;ATXN2L;NDUFS6;NUP153;ACTR10;BECN1;RANBP2;NXT2;PSMD8;PIK3C3;TBK1;RAB1A;PSMD9;ATP5PB;MAPK14;VCP;NDUFA5;UQCRC2;FUS;PSMC3;DCTN2;DERL1;BID;NUP50;SDHA;NDUFA10;ATXN2;SETX;TANK;PSMC6;DCTN6;SDHB
prerank,NF-kappa B signaling pathway,-0.23541509309287512,-0.9830908765819704,0.4444444444444444,0.8389953096918423,1.0,5/104,6.15%,PIAS4;GADD45A;NFKB2;TICAM1;CFLAR
prerank,mTOR signaling pathway,0.2662539651048678,0.9630046863503263,0.5333333333333333,0.6744777750691375,1.0,20/154,28.89%,AKT2;PRKAA1;LAMTOR3;DVL1;MAPK3;SOS1;DVL3;RPS6KA3;PIK3CB;STRADB;IGF1R;ATP6V1C1;RICTOR;AKT1;GRB2;CLIP1;MAPKAP1;ATP6V1A;FZD6;NRAS
prerank,Autophagy,0.2628207649960813,0.9629529786514097,0.550561797752809,0.6699510785921635,1.0,22/137,28.89%,GABARAP;RRAS2;AKT2;CTSD;PRKAA1;RAB7A;MAPK3;BECN1;PIK3C3;TBK1;MAPK8;RAB1A;PIK3CB;IGF1R;AKT1;PRKACA;TANK;ATG4B;HIF1A;SQSTM1;STX17;NRAS
prerank,Cholinergic synapse,-0.253931260645494,-0.9614168094981089,0.5263157894736842,0.8036207425590671,1.0,8/113,13.92%,ADCY7;AKT3;PIK3CA;ADCY6;CREB3L1;MAP2K1;JAK2;GNAI2
prerank,Melanoma,0.2870442324180516,0.9561298271376666,0.5432098765432098,0.6779125102044881,1.0,15/72,39.96%,AKT2;CDKN2A;MAPK3;PDGFB;CDH1;PIK3CB;IGF1R;AKT1;CDK4;NRAS;MET;EGFR;PDGFC;CCND1;BAX
prerank,Cushing syndrome,0.26489317233917775,0.9530611119824268,0.5232558139534884,0.678257092572425,1.0,11/155,20.73%,GNAS;USP8;AHR;CDKN2A;CTNNB1;DVL1;MAPK3;DVL3;MEN1;RAP1B;PRKACA
prerank,Non-small cell lung cancer,0.2873291217890461,0.9503539544485677,0.5238095238095238,0.6797792372335174,1.0,16/72,39.96%,AKT2;ERBB2;CDKN2A;MAPK3;SOS1;PIK3CB;AKT1;GRB2;CDK4;NRAS;MET;EGFR;EML4;PLCG1;CCND1;BAX
prerank,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.27837906596972894,0.935540294754797,0.5681818181818182,0.704034906278781,1.0,16/89,37.30%,IKBKG;CSNK2A1;AKT2;MAPK3;PIK3CB;JAK1;MAPK14;AKT1;HIF1A;MAP2K3;STAT1;NRAS;PPP3CA;EGFR;EML4;PLCG1
prerank,Glycolysis / Gluconeogenesis,0.3069011597356911,0.9279096865071355,0.573170731707317,0.7154330646356212,1.0,10/67,39.61%,ENO1;TPI1;PGM2;LDHA;ALDH3A2;FBP1;ALDH2;DLD;ALDH7A1;GAPDH
prerank,Purine metabolism,0.27015075315242887,0.9123698599519631,0.5657894736842105,0.7410294602203206,1.0,4/129,8.09%,ADK;AK2;ATIC;GUK1
prerank,Melanogenesis,0.2825201318123263,0.9117686525856882,0.5555555555555556,0.7375030441155523,1.0,10/101,28.89%,GNAS;CTNNB1;DVL1;MAPK3;DVL3;PRKACA;KITLG;CALM1;FZD6;NRAS
prerank,Apoptosis,0.2547366250068943,0.9081641269153111,0.6179775280898876,0.7397437999769435,1.0,20/142,30.86%,IKBKG;AKT2;ACTG1;CTSD;PARP4;CASP2;TUBA4A;MAPK3;BECN1;MAPK8;LMNA;PIK3CB;AKT1;BID;CTSZ;HTRA2;MAP3K14;NRAS;DFFA;ACTB
prerank,Thyroid hormone synthesis,0.28623778495628827,0.9021429727091849,0.618421052631579,0.7450124344159226,1.0,6/75,20.73%,GNAS;GPX8;GPX3;HSP90B1;GSR;PRKACA
prerank,Ribosome,0.2230171368672299,0.9012363347483913,0.6382978723404256,0.742092531460629,1.0,20/158,17.71%,RPL32;RPL11;RPL8;RPL37;RPL17;RPL15;RPL29;RPL13;MRPS2;RPL4;MRPL10;RPL22;MRPS7;RPSA;RPLP0;RPS20;RPS27;RPL41;RPL28;MRPL28
prerank,Aldosterone synthesis and secretion,-0.2564549226227379,-0.8982713056293219,0.64,0.8702055845351335,1.0,4/98,11.12%,ATP1A1;ADCY7;ADCY6;CREB3L1
prerank,Alzheimer disease,0.21387814597980312,0.8963871889406421,0.6979166666666666,0.7460874499731199,1.0,35/369,20.91%,PSMA5;APP;CSNK2A1;VDAC2;BACE2;AKT2;ADAM17;UQCRC1;CTNNB1;TUBA4A;DVL1;MAPK3;NDUFB5;SDHC;PPID;CSNK1E;NDUFS6;BECN1;PSMD8;CSNK1A1;PIK3C3;MAPK8;DKK1;PSMD9;DVL3;ATP5PB;ATP2A2;PIK3CB;NDUFA5;UQCRC2;PSMC3;AKT1;BID;SDHA;NDUFA10
prerank,Colorectal cancer,0.25873380587017264,0.8959862399602332,0.6625,0.7422206276775766,1.0,9/86,19.36%,AKT2;CTNNB1;MAPK3;TGFBR2;SOS1;MAPK8;PIK3CB;AKT1;GRB2
prerank,N-Glycan biosynthesis,0.28533474229341244,0.8939528304986212,0.6753246753246753,0.7417982464873332,1.0,9/50,30.70%,STT3A;ALG13;ALG2;ALG11;RPN2;ALG12;FUT8;MOGS;ALG8
prerank,Bladder cancer,0.2955452675435458,0.891386275219237,0.6455696202531646,0.7428967418809045,1.0,7/41,28.89%,ERBB2;CDKN2A;MAPK3;CDH1;THBS1;CDK4;NRAS
prerank,Central carbon metabolism in cancer,0.279734668198511,0.8851650780716435,0.6904761904761905,0.7502815491687561,1.0,8/70,19.26%,AKT2;ERBB2;GLS;MAPK3;G6PD;PIK3CB;LDHA;AKT1
prerank,PPAR signaling pathway,-0.2462886140307693,-0.883461850904192,0.64,0.8236882479288125,1.0,4/74,10.28%,OLR1;UBC;PLTP;NR1H3
prerank,Long-term depression,0.30410567073047956,0.8701027618086048,0.6493506493506493,0.7723458828171809,1.0,6/60,30.75%,GNAS;MAPK3;IGF1R;GNA12;NRAS;LYN
prerank,cGMP-PKG signaling pathway,0.24515474119292036,0.8579267781739609,0.7228915662650602,0.7882588234786108,1.0,7/167,8.36%,VDAC2;AKT2;GTF2I;PPP1CB;ROCK1;PPP1R12A;MAPK3
prerank,Natural killer cell mediated cytotoxicity,0.267532479871839,0.8578435434858032,0.6588235294117647,0.7835387107631699,1.0,11/131,30.39%,SHC1;IFNAR1;MAPK3;SOS1;FYN;PIK3CB;GRB2;BID;PAK1;NRAS;PPP3CA
prerank,RNA polymerase,0.2867516089632839,0.854191640796008,0.7,0.7854255733713353,1.0,7/31,42.26%,POLR2F;POLR2H;POLR2B;POLR2E;POLR2L;POLR3F;POLR3C
prerank,Progesterone-mediated oocyte maturation,0.2568246457401517,0.8414656866412791,0.7108433734939759,0.8029721171386268,1.0,16/100,33.64%,AKT2;MAPK3;MAPK8;RPS6KA3;PIK3CB;MAPK14;IGF1R;HSP90AA1;AKT1;PRKACA;ANAPC2;FZR1;ANAPC13;ANAPC7;CDC16;ANAPC5
prerank,VEGF signaling pathway,-0.21519193484785912,-0.8391363400088464,0.8823529411764706,0.830148679182125,1.0,8/59,18.37%,HSPB1;SPHK2;AKT3;PIK3CA;MAP2K1;MAPK11;BAD;MAPK1
prerank,Diabetic cardiomyopathy,0.20468165407237277,0.8259835784104851,0.8,0.8221618639690509,1.0,23/203,20.91%,VDAC2;AKT2;CTSD;UQCRC1;PPP1CB;NDUFB5;SDHC;TGFBR2;GFPT1;NDUFS6;MAPK8;G6PD;PDK2;ATP5PB;ATP2A2;PIK3CB;MAPK14;NDUFA5;UQCRC2;AKT1;SDHA;GSR;NDUFA10
prerank,TGF-beta signaling pathway,0.26210370729333754,0.8240273779898377,0.7922077922077922,0.8201777965012885,1.0,5/94,12.26%,SKP1;ROCK1;MAPK3;TGFBR2;TGIF1
prerank,Bile secretion,0.27651242687679495,0.807261495090181,0.6911764705882353,0.8410683699537272,1.0,2/90,1.74%,UGT1A6;GNAS
prerank,Huntington disease,0.18914463471480136,0.804155237158568,0.8315789473684211,0.8408155119496525,1.0,33/306,24.09%,PSMA5;AP2M1;VDAC2;UQCRC1;GPX8;POLR2F;GPX3;AP2B1;TUBA4A;NDUFB5;SIN3A;SDHC;NDUFS6;ACTR10;BECN1;PSMD8;PIK3C3;MAPK8;IFT57;POLR2H;PSMD9;ATP5PB;NDUFA5;UQCRC2;PSMC3;DCTN2;SDHA;NDUFA10;CLTC;PSMC6;AP2S1;DCTN6;SDHB
prerank,Basal transcription factors,0.24430297849075616,0.7787837473716738,0.7560975609756098,0.8724481914111339,1.0,5/45,17.89%,TAF15;GTF2I;TAF2;MNAT1;GTF2H1
prerank,Parkinson disease,0.17859998260594637,0.7481245627858084,0.9021739130434783,0.904874431464241,1.0,29/249,26.44%,PSMA5;VDAC2;GNAS;UBB;UCHL1;UQCRC1;MFN1;TUBA4A;NDUFB5;SDHC;NDUFS6;UBE2J2;UBE2G1;PSMD8;MAPK8;PSMD9;ATP5PB;NDUFA5;UQCRC2;PSMC3;SDHA;PRKACA;NDUFA10;PSMC6;PARK7;SDHB;CALM1;HTRA2;NDUFB6
prerank,Proteasome,0.22462099457527143,0.7464543569015041,0.8095238095238095,0.901583483119831,1.0,7/46,23.58%,PSMA5;PSMD8;PSMD9;PSME4;PSMC3;PSMC6;PSMF1
prerank,Prion disease,0.1747417260116526,0.7301791513702802,0.8736842105263158,0.9161580031027717,1.0,24/273,20.91%,CAV1;PSMA5;CSNK2A1;VDAC2;UQCRC1;TUBA4A;MAPK3;NDUFB5;SDHC;NDUFS6;PSMD8;MAPK8;LAMC1;PSMD9;ATP5PB;FYN;PIK3CB;MAPK14;NDUFA5;UQCRC2;PSMC3;SDHA;PRKACA;NDUFA10
prerank,GnRH secretion,0.27386531441629625,0.7301066305867222,0.8552631578947368,0.9112003162524355,1.0,4/64,19.26%,AKT2;MAPK3;PIK3CB;AKT1
prerank,Thermogenesis,0.18171489609628277,0.7251883577430712,0.9340659340659341,0.9125089808949293,1.0,25/232,21.22%,GNAS;ACTG1;ACTL6A;PRKAA1;SMARCD2;ARID1A;UQCRC1;SMARCC1;NDUFB5;SDHC;SMARCE1;NDUFS6;SOS1;ATP5MG;RPS6KA3;ATP5PB;MAPK14;NDUFA5;UQCRC2;KDM3A;GRB2;SDHA;PRKACA;NDUFA10;COX15
prerank,Pancreatic secretion,-0.21738675477669814,-0.7052275805862671,0.8333333333333334,0.9358698987419454,1.0,4/102,9.93%,ATP1A1;ADCY7;RHOA;ADCY6
prerank,Antigen processing and presentation,0.23013702333738117,0.6828167100696843,0.8552631578947368,0.9521719796374835,1.0,5/78,26.14%,B2M;PDIA3;HSP90AA1;NFYC;NFYA
prerank,Nucleotide excision repair,0.21525559526595384,0.6691092394308448,0.8888888888888888,0.9592580626318223,1.0,8/47,37.61%,CUL4B;MNAT1;GTF2H1;RFC1;CUL4A;ERCC5;RPA1;RAD23B
prerank,Glycerophospholipid metabolism,0.19426472635578768,0.6411173962842062,0.9146341463414634,0.976077026133773,1.0,15/98,42.55%,DGKZ;MBOAT7;PNPLA6;CDS1;PEMT;LPGAT1;GNPAT;PISD;LPIN3;MBOAT2;PLA2G12A;ETNK1;TAZ;GPD2;AGPAT3
prerank,Pyruvate metabolism,0.21549371878231208,0.6256803312250421,0.8823529411764706,0.9801322168701362,1.0,7/47,37.60%,ACAT2;LDHA;ALDH3A2;ME1;ALDH2;DLD;ALDH7A1
prerank,Longevity regulating pathway,0.17884775240613532,0.6171651789467228,0.9876543209876543,0.9804203686341526,1.0,7/102,20.73%,AKT2;PRKAA1;ADIPOR1;PIK3CB;IGF1R;AKT1;PRKACA
prerank,p53 signaling pathway,0.19290135337062314,0.5833416492417226,0.9625,0.9893858257038474,1.0,10/73,39.96%,CDKN2A;THBS1;EI24;BID;CDK4;CCNG1;COP1;CCND1;CASP3;BAX
prerank,Rheumatoid arthritis,0.20026732720831633,0.5435447127466306,0.9743589743589743,0.9971681140821612,1.0,7/93,37.27%,ATP6V0E1;ATP6V1C1;ATP6AP1;ATP6V1A;ATP6V0A1;ATP6V0C;TGFB2
prerank,Peroxisome,0.1599516967463799,0.49626514546908307,0.9863013698630136,1.0,1.0,16/82,53.26%,HSD17B4;AGPS;PEX19;DECR2;GNPAT;ACSL4;ECI2;ABCD3;CAT;MPV17;FAR1;SCP2;PEX2;IDH2;PEX16;SLC25A17
prerank,Glycerolipid metabolism,0.1564048060657043,0.46239301429122615,1.0,0.9979093244131175,1.0,1/61,1.15%,DGKZ
